Evidence
Adv Sci (Weinh). 2024 Feb 7:e2303775. doi: 10.1002/advs.202303775. Online ahead of print.
ABSTRACT
The spread of prion-like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer’s disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion-like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte-activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron-to-neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.
PMID:38327094 | DOI:10.1002/advs.202303775
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease
- Precision proteoform design for 4R tau isoform selective templated aggregation
- Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
- Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation
- G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
- Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy
- G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model
- Sleep disruption precedes forebrain synaptic Tau burden and contributes to cognitive decline in a sex-dependent manner in the P301S Tau transgenic mouse model
- Tau follows principal axes of functional and structural brain organization in Alzheimer's disease
- Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry
- Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model
- Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease
- Tau propagation in the brain olfactory circuits is associated with smell perception changes in aging
- Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
- Long-Term High-Fat Diet Consumption Aggravates β-Amyloid Deposition and Tau Pathology Accompanied by Microglial Activation in an Alzheimer's Disease Model
- Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
- Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects
- The Role of Glial Cells in Neurobiology and Prion Neuropathology
- The Role of Glial Cells in Neurobiology and Prion Neuropathology
- Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study
- Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus
- Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
- Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G
- The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease
- The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease
- Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3
- 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy
- Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
- Hyperphosphorylated tau in Alzheimer's disease disseminates along pathways predicted by the Structural Model for Cortico-cortical Connections
- Overexpression of pathogenic tau in astrocytes causes a reduction in AQP4 and GLT1, an immunosuppressed phenotype and unique transcriptional responses to repetitive mild TBI without appreciable changes in tauopathy
- Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammation in SH-SY5Y and HMC3 cells
- Autophagy preferentially degrades non-fibrillar polyQ aggregates
- Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice
- Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life
- Genomic stress and impaired DNA repair in Alzheimer disease
- Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Coeruleus Degeneration and Hippocampal Amyloid-β42 Accumulation
- β-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Autophagy and exosomes; inter-connected maestros in Alzheimer's disease
- Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation
- Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease
- Personalized whole-brain neural mass models reveal combined Ab and tau hyperexcitable influences in Alzheimer's disease
- β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer's disease
- Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
- Cerebrospinal fluid a-synuclein adds the risk of cognitive decline and is associated with tau pathology among non-demented older adults
- Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
Evidence Blueprint
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Different Tau Fibril Types Reduce Prion Level In Chronically And De Novo Infected Cells
- Self-Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
- A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
- Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS
- Tau and Alzheimer's disease: Past, present and future
- D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Tau seeding without tauopathy
- Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease
- Distinct tau folds initiate templated seeding and alter the post-translational modification profile
- Precision proteoform design for 4R tau isoform selective templated aggregation
- Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer's disease tau
- Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations
- Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells
- Super-resolution imaging unveils the self-replication of tau aggregates upon seeding
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Local structural preferences in shaping tau amyloid polymorphism
- Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer's disease-related mouse models
- Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
- Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
- Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation
- G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia
- Passive tau-based immunotherapy for tauopathies
- New insights into the therapeutic approaches for the treatment of tauopathies
- Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
- Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response
- p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- Disentangling tau: One protein, many therapeutic approaches
- Ensemble-based design of tau to inhibit aggregation while preserving biological activity
- Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology
- Lateral geniculate body is spared of tau pathology in Pick disease
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- Synapses do not facilitate prion-like transfer of alpha-synuclein: a quantitative study in reconstructed unidirectional neural networks
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin
- Primary retinal tauopathy: A tauopathy with a distinct molecular pattern
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
- Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry
- Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy
- P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes
- CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults
- APOEε4 potentiates amyloid β effects on longitudinal tau pathology
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study